GlassScriptPhysician profile
Teresa D Macpherson
NPI 1801894191
$664.14
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $35.29 · 2021: $163 · 2022: $51.66 · 2023: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $119.69 | 2019-2023 | Bexsero, Pediarix, Rotarix |
| Corium, LLC | $105.23 | 2022-2023 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $105.21 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $64.99 | 2019 | |
| Pfizer INC. | $60.87 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $57.72 | 2021-2023 | Qelbree |
| Adlon Therapeutics L.P. | $46.13 | 2021 | |
| Genentech USA, INC. | $28.68 | 2019-2020 | |
| Seqirus USA INC | $28.09 | 2021-2023 | Flucelvax Quadrivalent |
| Tris Pharma INC | $24.69 | 2020-2021 | |
| Phadia US INC. | $11.45 | 2019 | |
| Sanofi Pasteur INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teresa Macpherson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.